Sign In
Buy CLSDQ
Clearside Biomedical Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 6.83M and sold 1.66M CLSDQ shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 6.83M shares |
| ● Sell | 1.66M shares |
|
84% Buy Activity
Moderate Negative Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jan 19, 2022 Sell |
Deignan Charles A. Chief Financial Officer |
8 833 Value: $18.5K |
||
|
Jan 19, 2022 Sell |
Ciulla Thomas Chief Medical Officer |
9 050 Value: $19.3K |
||
|
Jan 19, 2022 Sell |
Lasezkay George M CEO |
10 800 Value: $22.9K |
||
|
Jan 18, 2022 Buy |
Ciulla Thomas Chief Medical Officer |
46 250 Value: $0 |
||
|
Jan 18, 2022 Buy |
Ciulla Thomas Chief Medical Officer |
138 750 Value: $303.9K |
||
|
Jan 18, 2022 Buy |
Deignan Charles A. Chief Financial Officer |
46 250 Value: $0 |
||
|
Jan 18, 2022 Buy |
Deignan Charles A. Chief Financial Officer |
138 750 Value: $303.9K |
||
|
Jan 18, 2022 Buy |
Deignan Charles A. Chief Financial Officer |
43 750 Value: $0 |
||
|
Jan 18, 2022 Buy |
Deignan Charles A. Chief Financial Officer |
131 250 Value: $287.4K |
||
|
Jan 18, 2022 Buy |
Ciulla Thomas Chief Medical Officer |
43 750 Value: $0 |
||
|
Jan 18, 2022 Buy |
Ciulla Thomas Chief Medical Officer |
131 250 Value: $287.4K |
||
|
Jan 18, 2022 Buy |
Lasezkay George M CEO |
97 500 Value: $0 |
||
|
Jan 18, 2022 Buy |
Lasezkay George M CEO |
292 500 Value: $640.6K |
||
|
Jan 11, 2022 Sell |
Lasezkay George M CEO |
5 100 Value: $12.5K |
||
|
Jan 10, 2022 Buy |
Humphries William D. Director |
22 727 Value: $3K |
||
|
Jan 10, 2022 Buy |
Humphries William D. Director |
22 727 Value: $3K |
||
|
Oct 29, 2021 Buy |
Hutson Nancy J Director |
15 000 Value: $31.4K |
||
|
Oct 29, 2021 Buy |
Hutson Nancy J Director |
25 000 Value: $50.0K |
||
|
Oct 29, 2021 Buy |
Hutson Nancy J Director |
15 000 Value: $31.4K |
||
|
Oct 29, 2021 Buy |
Hutson Nancy J Director |
25 000 Value: $50.0K |
||
|
Sep 21, 2021 Sell |
Ciulla Thomas Chief Medical Officer |
2 560 Value: $16.4K |
||
|
Sep 21, 2021 Sell |
Lasezkay George M CEO |
3 525 Value: $22.8K |
||
|
Sep 21, 2021 Sell |
Deignan Charles A. Chief Financial Officer |
2 800 Value: $17.9K |
||
|
Aug 30, 2021 Sell |
Whitmore Bradford T 10 Percent Owner |
99 400 Value: $702.1K |
||
|
Feb 10, 2021 Sell |
Thorp Clay Director |
32 873 Value: $145.6K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
